{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2013"],"condition":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"disease":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2149306"],"location":["China"],"study_start_month":["8"],"keyword":["Bevacizumab"],"repository":["ECRIN MDR"],"study_status":["Not provided"],"additional_accession":[]},"is_claimable":false,"name":"Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer","description":"To assess the safety profile of bevacizumab in combination with chemotherapy for the treatment of metastatic colorectal cancer","dates":{"creation":"2013-08-15"},"accession":"2149306","cross_references":{"ClinicalTrials___gov":["NCT01912443"]}}